ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Coral Laboratories will hold a board meeting on 14 Nov 2026 to consider unaudited standalone half-yearly results for the period ended September 2026, plus other business. Trading window closes from 1 Oct to 16 Nov 2026.
The company has filed its quarterly shareholding pattern statement for the quarter ended September 30, 2026, as required under SEBI Regulation 31.
Coral Laboratories Limited held its 44th Annual General Meeting on September 29, 2026. Shareholders approved the FY2025-26 audited financial statements, declared a final dividend, and re-appointed retiring directors.
Coral Laboratories Ltd's board approved the Cost Audit Report for fiscal year 2025-26. This routine meeting involved no other material financial or business decisions.
Coral Laboratories intimated BSE of a board meeting scheduled for 25 September 2026. The agenda includes approval of the cost audit report for FY 2025-26.
Coral Laboratories Limited has issued a notice for its Annual General Meeting scheduled for June 29, 2026. Agenda items include adoption of financial statements and dividend declaration.
Coral Laboratories Limited has released its Annual Report for FY 2025-26. The 44th Annual General Meeting is scheduled for September 29, 2026, via video conferencing.
Coral Laboratories Ltd has scheduled its 44th Annual General Meeting for September 29, 2026. The company has also fixed the book closure dates and record date for final dividend.
Coral Laboratories Ltd reported revenue from operations of ₹29.6 Cr (+57.4% YoY) and net profit of ₹5.4 Cr (+107.7% YoY) for Q1 FY27.
Coral Laboratories Ltd scheduled a board meeting for August 14, 2026. The meeting will focus on approving unaudited standalone financial results for the June 2026 quarter.
Coral Laboratories Ltd announced the results of a postal ballot. Shareholders approved the increase in remuneration for Ms. Meera Doshi.
Coral Laboratories clarified to BSE that recent price movement is market‑driven with no insider knowledge. The company will continue complying with Regulation 30 disclosures.
Coral Laboratories recommended a final dividend of ₹2.00 per share for FY 2025-26. The 20% payout remains subject to shareholder approval at the upcoming AGM.
Coral Laboratories Ltd reported revenue from operations of ₹26.5 Cr (-5.7% YoY) and net profit of ₹5.2 Cr (+85.7% YoY) for Q4 FY26.
Coral Laboratories approved FY2026 audited results and recommended a ₹2.00 final dividend. The board also appointed new internal and cost auditors for the next fiscal year.
Coral Laboratories Limited filed its Annual Secretarial Compliance Report for FY2026. The report confirms overall regulatory compliance with standard SEBI listing and disclosure requirements.
Coral Laboratories scheduled a board meeting for May 30, 2026. The board will consider FY26 financial results and a potential final dividend recommendation.